Elias Sayour is an Oncology physician affiliated with University of Florida Health. OpenAlex indexes 243 publications with 3,851 citations (h-index 31); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-273-9000Registry record last updated 21 Nov 2013.
Clinical trials
- Universal Immunization to Fortify Immunotherapy Efficacy and Response
Sponsor: University of Florida
- RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
5 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020
University of Florida
FY2026$1,245,669R01FD007268 - Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
University of Florida
FY2026$767,498R37CA251978
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading
Nature Biomedical Engineering
2025 - 419 SARS-CoV-2 mRNA vaccines sensitize immunologically ‘cold’ tumors to immune checkpoint blockade
Regular and Young Investigator Award Abstracts
2025 - Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response
Journal of Clinical Investigation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Jamie Conti, MD
University of Florida Health
Westley Reeves, MD
University of Florida Health
Borna Mehrad, MD
University of Florida Health
Joanne Lagmay, MD
University of Florida Health
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”